Precigen

PGEN · NASDAQ

$6.83+$0.17 (+2.55%)TodayMarket closed · Oct 20, 7:30 PM ET

Prev close $6.66

Latest news

NewsOct 7, 8:02 AM ETAvi Kapoor
Constellation Brands, Caribou Biosciences And Other Big Stocks Moving Lower In Wednesday’s Pre-Market Session
Press releaseSep 21, 7:00 AM ETPRNewswire
Precigen Receives FDA Platform Technology Designation for AdenoVerse Platform
Press releaseAug 25, 7:00 AM ETACCESS Newswire
Precigen's Strong Second Quarter Signals Significant Growth, Validates AdenoVerse Platform; PRGN-2009 Advances in HPV-Driven Cancers
NewsAug 4, 5:06 PM ET
12 Health Care Stocks Moving In Tuesday's After-Market Session
Press releaseAug 4, 4:01 PM ETPRNewswire
Precigen Reports Second Quarter 2026 Financial Results Highlighted by Accelerating PAPZIMEOS Revenue Growth
Press releaseJul 21, 8:00 AM ETPRNewswire
Precigen to Announce Second Quarter 2026 Financial Results and Provide Business Updates on August 4
Press releaseJun 15, 6:40 AM ETACCESS Newswire
Precigen Gains Advantage as PAPZIMEOS Granted Orphan Drug Exclusivity by FDA; Long-Term Data From Clinical Study Encouraging
Press releaseJun 11, 8:00 AM ETPRNewswire
Precigen and the Recurrent Respiratory Papillomatosis Foundation Recognize International RRP Awareness Day by Elevating Patient and Community Voices
Press releaseMay 30, 2:30 PM ETPRNewswire
Precigen Presents New Long-Term Durability Data for PAPZIMEOS, Recently Granted Seven-Year Market Exclusivity, Demonstrating Complete Responses Beyond 4 Years
Press releaseMay 27, 7:00 AM ETPRNewswire
Precigen Receives Orphan Drug Exclusivity for PAPZIMEOS (zopapogene imadenovec-drba) in the United States
Press releaseMay 26, 8:05 AM ETPRNewswire
Precigen to Participate in Fireside Chats with J.P. Morgan and at the Goldman Sachs 47th Annual Global Healthcare Conference
NewsMay 13, 5:41 PM ET
Transcript: Precigen Q1 2026 Earnings Conference Call
Press releaseMay 13, 4:05 PM ETPRNewswire
Precigen Reports First Quarter 2026 Financial Results and Business Updates
NewsMay 13, 7:11 AM ET
Earnings Scheduled For May 13, 2026
Press releaseMay 7, 4:05 PM ETPRNewswire
Precigen to Announce First Quarter 2026 Financial Results and Provide Business Updates on May 13
Press releaseMar 30, 8:30 AM ETPRNewswire
Precigen to Participate in a Fireside Chat with H.C. Wainwright on March 31
NewsMar 26, 1:05 PM ET
12 Health Care Stocks Moving In Thursday's Intraday Session
NewsMar 26, 12:09 PM ETAvi Kapoor
Crude Oil Gains 4%; Commercial Metals Posts Mixed Q2 Results
NewsMar 26, 12:08 PM ETAvi Kapoor
These Analysts Boost Their Forecasts On Precigen Following Q4 Results
NewsMar 26, 8:05 AM ET
12 Health Care Stocks Moving In Thursday's Pre-Market Session
NewsMar 26, 5:47 AM ETAvi Kapoor
Why Navan Shares Are Trading Higher By Over 25%; Here Are 20 Stocks Moving Premarket
NewsMar 25, 5:05 PM ET
12 Health Care Stocks Moving In Wednesday's After-Market Session
Press releaseMar 25, 4:05 PM ETPRNewswire
Precigen Reports Full Year 2025 Financial Results and Business Updates
Press releaseMar 11, 4:05 PM ETPRNewswire
Precigen to Announce Full Year 2025 Financial Results and Provide Business Updates on March 25
Press releaseJan 20, 8:05 AM ETPRNewswire
New Expert Consensus Published in The Laryngoscope Recommends PAPZIMEOS (zopapogene imadenovec) as the New Standard of Care First-Line Treatment for Adults with Recurrent Respiratory Papillomatosis
Press releaseJan 12, 8:00 AM ETPRNewswire
Precigen Showcases Rapid Commercialization Momentum and Growing Market Adoption of First-and-Only FDA-Approved Therapy for RRP at the 44th Annual J.P. Morgan Healthcare Conference
Press releaseJan 5, 4:05 PM ETPRNewswire
Precigen to Present at the 44th Annual J.P. Morgan Healthcare Conference
NewsDec 29, 12:33 PM ETAvi Kapoor
Why Ultragenyx Pharmaceutical Shares Are Trading Lower By Around 42%? Here Are Other Stocks Moving In Monday's Mid-Day Session
NewsDec 29, 10:30 AM ETAvi Kapoor
DigitalBridge Group, Eightco Holdings, Palisade Bio And Other Big Stocks Moving Higher On Monday
NewsNov 14, 12:06 PM ET
12 Health Care Stocks Moving In Friday's Intraday Session
Press releaseNov 13, 4:05 PM ETPRNewswire
Precigen Reports Third Quarter 2025 Financial Results and Business Updates
NewsNov 12, 10:02 AM ET
Exploring Precigen's Earnings Expectations
Press releaseNov 6, 4:30 PM ETPRNewswire
Precigen to Announce Third Quarter 2025 Financial Results and Provide Business Updates on November 13
Press releaseOct 13, 7:00 AM ETPRNewswire
Precigen Announces Long-Term Follow-Up Results Highlighting Ongoing Durable Complete Responses after Treatment with PAPZIMEOS, the First and Only FDA-approved Therapy for Adults with Recurrent Respiratory Papillomatosis
Press releaseSep 3, 7:00 AM ETPRNewswire
Precigen Announces Up to $125 Million Non-Dilutive Financing
Press releaseAug 25, 8:05 AM ETPRNewswire
Precigen to Participate in Upcoming Virtual Fireside Chats Hosted by Cantor and H.C. Wainwright
NewsAug 19, 8:01 AM ETAvi Kapoor
Why Palo Alto Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket
NewsAug 19, 6:21 AM ETAvi Kapoor
Fabrinet, Adecoagro And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
NewsAug 15, 5:22 PM ET
12 Health Care Stocks Moving In Friday's After-Market Session
NewsAug 15, 1:07 PM ET
12 Health Care Stocks Moving In Friday's Intraday Session
NewsAug 15, 12:28 PM ETAvi Kapoor
Crude Oil Down 1%; US Retail Sales Rise 0.5% In July
NewsAug 15, 10:39 AM ETAvi Kapoor
This Salesforce Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Friday
NewsAug 15, 10:14 AM ETAvi Kapoor
Evolv Technologies, Precigen, Hesai Group And Other Big Stocks Moving Higher On Friday
NewsAug 15, 8:46 AM ETAvi Kapoor
Why KULR Technology Shares Are Trading Higher By Around 19%; Here Are 20 Stocks Moving Premarket
NewsJul 2, 10:22 AM ETAvi Kapoor
Hut 8, Greenbrier And Other Big Stocks Moving Higher On Tuesday

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.

Latest news

Constellation Brands, Caribou Biosciences And Other Big Stocks Moving Lower In Wednesday’s Pre-Market Session

Precigen Receives FDA Platform Technology Designation for AdenoVerse Platform

Precigen's Strong Second Quarter Signals Significant Growth, Validates AdenoVerse Platform; PRGN-2009 Advances in HPV-Driven Cancers

12 Health Care Stocks Moving In Tuesday's After-Market Session

Precigen Reports Second Quarter 2026 Financial Results Highlighted by Accelerating PAPZIMEOS Revenue Growth

Precigen to Announce Second Quarter 2026 Financial Results and Provide Business Updates on August 4

Precigen Gains Advantage as PAPZIMEOS Granted Orphan Drug Exclusivity by FDA; Long-Term Data From Clinical Study Encouraging

Precigen and the Recurrent Respiratory Papillomatosis Foundation Recognize International RRP Awareness Day by Elevating Patient and Community Voices

Precigen Presents New Long-Term Durability Data for PAPZIMEOS, Recently Granted Seven-Year Market Exclusivity, Demonstrating Complete Responses Beyond 4 Years

Precigen Receives Orphan Drug Exclusivity for PAPZIMEOS (zopapogene imadenovec-drba) in the United States

Precigen to Participate in Fireside Chats with J.P. Morgan and at the Goldman Sachs 47th Annual Global Healthcare Conference

Transcript: Precigen Q1 2026 Earnings Conference Call

Precigen Reports First Quarter 2026 Financial Results and Business Updates

Earnings Scheduled For May 13, 2026

Precigen to Announce First Quarter 2026 Financial Results and Provide Business Updates on May 13

Precigen to Participate in a Fireside Chat with H.C. Wainwright on March 31

12 Health Care Stocks Moving In Thursday's Intraday Session

Crude Oil Gains 4%; Commercial Metals Posts Mixed Q2 Results

These Analysts Boost Their Forecasts On Precigen Following Q4 Results

12 Health Care Stocks Moving In Thursday's Pre-Market Session

Why Navan Shares Are Trading Higher By Over 25%; Here Are 20 Stocks Moving Premarket

12 Health Care Stocks Moving In Wednesday's After-Market Session

Precigen Reports Full Year 2025 Financial Results and Business Updates

Precigen to Announce Full Year 2025 Financial Results and Provide Business Updates on March 25

New Expert Consensus Published in The Laryngoscope Recommends PAPZIMEOS (zopapogene imadenovec) as the New Standard of Care First-Line Treatment for Adults with Recurrent Respiratory Papillomatosis

Precigen Showcases Rapid Commercialization Momentum and Growing Market Adoption of First-and-Only FDA-Approved Therapy for RRP at the 44th Annual J.P. Morgan Healthcare Conference

Precigen to Present at the 44th Annual J.P. Morgan Healthcare Conference

Why Ultragenyx Pharmaceutical Shares Are Trading Lower By Around 42%? Here Are Other Stocks Moving In Monday's Mid-Day Session

DigitalBridge Group, Eightco Holdings, Palisade Bio And Other Big Stocks Moving Higher On Monday

12 Health Care Stocks Moving In Friday's Intraday Session

Precigen Reports Third Quarter 2025 Financial Results and Business Updates

Exploring Precigen's Earnings Expectations

Precigen to Announce Third Quarter 2025 Financial Results and Provide Business Updates on November 13

Precigen Announces Long-Term Follow-Up Results Highlighting Ongoing Durable Complete Responses after Treatment with PAPZIMEOS, the First and Only FDA-approved Therapy for Adults with Recurrent Respiratory Papillomatosis

Precigen Announces Up to $125 Million Non-Dilutive Financing

Precigen to Participate in Upcoming Virtual Fireside Chats Hosted by Cantor and H.C. Wainwright

Why Palo Alto Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket

Fabrinet, Adecoagro And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

12 Health Care Stocks Moving In Friday's After-Market Session

12 Health Care Stocks Moving In Friday's Intraday Session

Crude Oil Down 1%; US Retail Sales Rise 0.5% In July

This Salesforce Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Friday

Evolv Technologies, Precigen, Hesai Group And Other Big Stocks Moving Higher On Friday

Why KULR Technology Shares Are Trading Higher By Around 19%; Here Are 20 Stocks Moving Premarket

Hut 8, Greenbrier And Other Big Stocks Moving Higher On Tuesday